1h Free Analyst Time
The fetal bovine serum market is forecasted to grow by USD 364.2 million during 2024-2029, accelerating at a CAGR of 6.1% during the forecast period. The report on the fetal bovine serum market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising adoption of stem cell applications, increasing prevalence of chronic diseases, and livestock industry growth.
The fetal bovine serum market is segmented as below:
By Application
- Biopharmaceuticals
- Human and animal vaccine
- Others
By End-user
- Pharmaceutical and biopharmaceutical companies
- Contract research organization
- Academic and research organization
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the fetal bovine serum market covers the following areas:
- Fetal Bovine Serum Market sizing
- Fetal Bovine Serum Market forecast
- Fetal Bovine Serum Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Application
9 Market Segmentation by End-user
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global fetal bovine serum market: Animal Technologies Inc., Atlas Biologicals Inc., Bio Techne Corp., Celtic Molecular Diagnostics, Corning Inc., Danaher Corp., GeminiBio, GeneTex Inc., Grifols SA, HiMedia Laboratories Pvt. Ltd., Itoham Yonekyu Holdings Inc., Merck KGaA, MP Biomedicals Inc., Nucleus Biologics, PAN Biotech, Rocky Mountain Biologicals, Sartorius AG, TCS Biosciences Ltd., Thermo Fisher Scientific Inc., and Tissue Culture Biologicals.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing application in cell-based pharmaceutical research."
According to the report, one of the major drivers for this market is the rising adoption of stem cell applications.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Animal Technologies Inc.
- Atlas Biologicals Inc.
- Bio Techne Corp.
- Celtic Molecular Diagnostics
- Corning Inc.
- Danaher Corp.
- GeminiBio
- GeneTex Inc.
- Grifols SA
- HiMedia Laboratories Pvt. Ltd.
- Itoham Yonekyu Holdings Inc.
- Merck KGaA
- MP Biomedicals Inc.
- Nucleus Biologics
- PAN Biotech
- Rocky Mountain Biologicals
- Sartorius AG
- TCS Biosciences Ltd.
- Thermo Fisher Scientific Inc.
- Tissue Culture Biologicals
